2. Бодня О.С. Наследственный ангиоотек – что мы знаем об этом заболевании? Терапия. 2020;2:100–6.

3. Пампура А.Н., Плавунов Н.Ф., Бодня О.С. и др. Наследственный ангиоотек: от диагноза к оптимальной терапии. Учебно-методические рекомендации. М., 2019.

4. Maurer M., Magerl M., Betschel S., et al The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update. Allergy.2022;00:1–30. Doi: 10.1111/all.15214.

5. Ponard D., Gaboriaud C., Charignon D., et al. SERPING1 mutation update: mutation spec-trum and C1 inhibitor phenotypes. Hum Mutat. 2020;41:38–57. Doi: 10.1002/humu.23917.

6. Bork K., Barnstedt S.E., Koch P., Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet. 2000;356(9225):213–17. Doi: 10.1016/S0140-6736(00)02483-1.

7. Dewald G., Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Comm. 2006;343(4):1286–89. Doi: 10.1016/j.bbrc.2006.03.092.

8. Bafunno V., Firinu D., D’Apolito M., et al. Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema. J Allergy Clin Immun. 2018;141(3):1009–17. Doi: 10.1016/j.jaci.2017.05.020.

9. Bork K., Wulff K., Rossmann H., et al. Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the Nterminal cleavage site of bradykinin. Allergy. 2019;74(12):2479–81. Doi: 10.1111/all.13869.

10. Ariano A., D’Apolito M., Bova M., et al. A myoferlin gain-of-function variant associates with a new type of hereditary angioedema. Allergy. 2020;75(11):2989–92. Doi: 10.1111/all.14454.

11. Bork K., Wulff K., Mohl B.S., et al. Novel hereditary angioedema linked with a heparan sulfate 3-O-sulfotransferase 6 gene mutation. J Allergy Clin Immunol. 2021;148(4):1041–48. Doi: 10.1016/j.jaci.2021.01.011.

12. Bork K., Wulff K., Witzke G., Hardt J. Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII). Allergy. 2017;72(2):320–24. Doi: 10.1111/all.13076.

13. Bork K., Wulff K., Witzke G., et al. Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene. Orphanet J Rare Dis. 2020;15(1):52. Doi: 10.1186/s13023-020-1334-8.

14. Zuraw B.L., Bork K., Binkley K.E., et al. Hereditary angioedema with normal C1inhibitor function: consensus of an international expert panel. Allergy Asthma Proc. 2012;33:S145–56. Doi: 10.2500/aap.2012.33.3627.

15. Bork K., Barnstedt S.E. Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. J Am Dent Assoc. 2003;134(8):1088–94. Doi: 10.14219/jada.archive.2003.0323

16. Belbézier A., Bocquet A., Bouillet L. Idiopathic angioedema: cur-rent challenges. J Asthma Allergy. 2020;13:137–44. Doi: 10.2147/JAA.S205709.

17. Martinez-Saguer I., Graff J., Rusicke E., et al. Does early clinical manifestation of hereditary angioedema (HAE) influence the clinical course of the disease? J Allergy Clin Immun. 2013;131(2):AB30.

18. Campos R.A., et al. Hereditary angioedema: a disease seldom diagnosed by pediatricians. J Pediatr. 2021;97:S10–6. Doi: 10.1016/j.jped.2020.10.011.

19. Christiansen S.C., Davis D.K., Castaldo A.J., Zuraw B.L. Pediatric hereditary angioedema: onset, diagnostic delay, and disease severity. Clin Pediatr. (Phila). 2016;55(10):935–42. Doi: 10.1177/0009922815616886.

20. Aabom A., Andersen K.E., Fagerberg C., et al. Clinical characteristics and real-life diagnostic approaches in all Danish children with hereditary angioedema. Orphanet J Rare Dis. 2017;12:55. Doi: 10.1186/s13023-017-0604-6.

21. Magerl M., Doumoulakis G., Kalkounou I., et al. Characterization of prodromal symptoms in alarge population of patients with hereditary angio-oedema. Clin Exp Dermatol. 2014;39:298–303. Doi: 10.1111/ced.12285.

22. Busse P.J., Christiansen S.C. Hereditary angioedema. N EnglJ. Med. 2020;382:1136–48. Doi: 10.1056/NEJMra1808012.

23. Wahn V., Aberer W., Aygören-Pürsün E., et al. Hereditary angioedema in children and adolescents – a consensus update on therapeutic strategies for German-speaking countries. Pediatr Allergy Immunol. 2020;31:974–89. Doi: 10.1111/pai.13309.

24. Martinez-Saguer I., Rusicke E., Aygoren-Pursun E., et al. Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate. Am J Obstet Gynecol. 2010;203(2):e131–37. Doi: 10.1016/j.ajog.2010.03.003.

25. Riedl M.A., Maurer M., Bernstein J.A., et al. Lanadelumab demonstrates rapid and sus-tained prevention of hereditary angioedema attacks. Allergy. 2020;75:2879–87. Doi: 10.1111/all.14416.

26. Levy D., Caballero T., Hussain I., et al. Long-term efficacy of subcutaneous C1 inhibitor inpediatric patients with hereditary angioedema. Pediatr Allergy Immunol Pulmonol. 2020;33:136–41. Doi: 10.1089/ped.2020.1143.